文献速递运动医学关节外科

自体真皮成纤维细胞注射降低关节镜下肩袖修复术后再撕裂率的前瞻性随机对照试验

Efficacy of an Autologous Dermal Fibroblast Injection in Reducing the Retear Rate After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial.
PubMed 文献 · Am J Sports Med · 2025-01-28

该前瞻性随机对照试验纳入86例全层肩袖撕裂>2 cm患者,比较关节镜下肩袖修复加自体真皮成纤维细胞注射与单纯修复的疗效。结果显示注射组再撕裂率5.6%(2/36)显著低于对照组24.3%(9/37)(P = .025),但两组功能评分和活动度在术后6个月和12个月无显著差异。

要点

  • 自体真皮成纤维细胞注射组再撕裂率5.6%(2/36),显著低于单纯修复组24.3%(9/37)(P = .025)。
  • 两组ASES、Constant和SST评分术后均显著改善(所有P值<.001)。
  • 术后6个月和12个月两组功能评分和活动度无显著差异(所有P值>.05)。

核心结论

  • 关节镜下肩袖修复术中在骨-肌腱界面应用自体真皮成纤维细胞可显著降低全层肩袖撕裂>2 cm患者的再撕裂率。
  • 自体真皮成纤维细胞注射可能是促进此类患者骨-肌腱界面愈合的有前景的生物学补充手段。
  • 但两组临床结局在术后6个月和1年时无显著差异。

研究设计与样本

  • 前瞻性随机对照试验,证据等级2级,共纳入86例患者并随机分为2组。
  • 自体真皮成纤维细胞组在关节镜下肩袖修复术中于骨与肌腱之间追加注射自体真皮成纤维细胞,对照组仅行关节镜下肩袖修复。
  • 从臀部取皮肤活检获取自体真皮成纤维细胞,培养约4周后于术前使用。
  • 关节镜下肩袖修复统一采用双排缝线桥技术以减少不同修复方法间的异质性。

主要发现

  • 共13例患者退出(自体真皮成纤维细胞组7例,对照组6例),原因为肩胛下肌腱撕裂、失访或撤回知情同意。
  • 再撕裂率自体真皮成纤维细胞组为5.6%(2/36),对照组为24.3%(9/37),自体真皮成纤维细胞组显著低于对照组(P = .025)。
  • 两组ASES评分、Constant评分和SST评分术后均显著改善(所有P值<.001)。
  • 术后6个月和12个月两组功能评分和活动度均无显著差异(所有P值>.05)。

关键数值与推荐

  • 主要评价指标为术后6个月磁共振成像评估的再撕裂率。
  • 次要评价指标包括基线及术后6个月和12个月的活动度、ASES评分、Constant评分和SST评分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Interest in biological augmentation for improving bone-tendon interface (BTI) healing after arthroscopic rotator cuff repair (ARCR) is growing. Dermal fibroblasts, known for collagen synthesis similar to tenocytes, have shown effectiveness in BTI healing in chronic rotator cuff tear (RCT) models in rabbits. However, no human clinical trials have been conducted. PURPOSE: To evaluate the clinical efficacy of autologous dermal fibroblasts (ADFs) for BTI healing after ARCR in patients with full-thickness RCTs >2 cm. STUDY DESIGN: Randomized controlled trial; Level of evidence, 2. METHODS: A total of 86 patients were prospectively enrolled and randomized into 2 groups: an additional ADF injection between the bone and tendon during ARCR (ADF group) or ARCR alone (control group). A skin biopsy from the buttock was performed to obtain ADFs, which were cultured for approximately 4 weeks before surgery. ARCR was standardized to the double-row suture bridge technique to reduce the heterogeneity in different repair methods. The primary variable for evaluating ADF efficacy was the retear rate using magnetic resonance imaging at 6 months postoperatively. Secondary variables included range of motion, the American Shoulder and Elbow Surgeons score, the Constant score, and the Simple Shoulder Test score at baseline and at 6 and 12 months postoperatively. RESULTS: Overall, 13 patients dropped out because of a subscapularis tendon tear, loss to follow-up, or the withdrawal of consent (7 in the ADF group and 6 in the control group). The retear rate was significantly lower in the ADF group (5.6% [2/36]) than in the control group (24.3% [9/37]) (P = .025). The American Shoulder and Elbow Surgeons, Constant, and Simple Shoulder Test scores showed significant improvement after surgery in both groups (all P values <.001). Functional scores and range of motion did not significantly differ between the 2 groups at 6 and 12 months (all P values >.05). CONCLUSION: ADF application into the BTI during ARCR significantly decreased the retear rate in patients with full-thickness RCTs >2 cm. Therefore, an ADF injection could be a promising biological supplement to enhance BTI healing in these patients. However, clinical outcomes showed no significant difference between the 2 groups at 6 months and 1 year postoperatively.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Kim YK, Kim YT, Won YS, et al. Efficacy of an Autologous Dermal Fibroblast Injection in Reducing the Retear Rate After Arthroscopic Rotator Cuff Repair: A Prospective Randomized Controlled Trial. Am J Sports Med. 2025. PMID: 39876067. doi:10.1177/03635465241311605

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。